Target intelligence / Profile preview

Respiratory mucus mucoproteins and extracellular DNA

Molecular classification
Glycoprotein, Nucleic acid, Structural component, Other
01

Overview

Respiratory mucus is a complex hydrogel primarily composed of water, gel-forming mucoproteins (mucins), and, in pathological states, high concentrations of extracellular DNA (Source: PubMed, PMID: 25108218). Mucins like MUC5AC and MUC5B provide the structural framework through disulfide cross-linking, while extracellular DNA released from infiltrating neutrophils significantly increases the viscosity and elasticity of the mucus (Source: NIH, StatPearls). In chronic respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), the accumulation of thick, tenacious mucus impairs mucociliary clearance, leading to airway obstruction and recurrent infections (Source: PubMed, PMID: 30243718). Therapeutic strategies target these components to reduce mucus viscosity; for instance, mucolytics like N-acetylcysteine disrupt mucin disulfide bonds, while dornase alfa enzymatically digests the DNA polymers (Source: FDA, Pulmozyme Label). Modulating the physical properties of respiratory mucus is a critical approach to improving lung function and reducing the frequency of pulmonary exacerbations (Source: PubMed, PMID: 29107110).

Other names
Airway mucusSputum componentsMucus glycoproteinsExtracellular DNA (eDNA)
02

Mechanism of action

The mechanism involves the chemical reduction of disulfide bridges between mucin monomers to liquefy mucus, and the enzymatic cleavage of long-chain extracellular DNA into smaller fragments to reduce the viscoelasticity of purulent sputum (Source: StatPearls; PubMed, PMID: 15191020).

03

Biological functions

Mucociliary clearance (Source: PubMed, PMID: 25108218)Innate immunity (Source: NIH, StatPearls)Physical barrier (Source: PubMed, PMID: 30243718)Other
04

Disease associations

Inflammation (Source: NIH, StatPearls)Infection (Source: PubMed, PMID: 30243718)Cystic fibrosis (Source: FDA, Pulmozyme Label)Chronic obstructive pulmonary disease (COPD) (Source: PubMed, PMID: 29107110)Other
05

Safety considerations

Bronchospasm (Source: FDA, Pulmozyme Label)Airway irritation (Source: PubMed, PMID: 29107110)Cough (Source: StatPearls)Voice alteration (Source: FDA, Pulmozyme Label)
06

Interacting drugs

Dornase alfa

4 more in the full profile.

07

Biomarkers

Sputum viscosity (Source: PubMed, PMID: 25108218)Forced expiratory volume in 1 second (FEV1) (Source: NIH, StatPearls)Sputum DNA concentration (Source: PubMed, PMID: 15191020)MUC5AC/MUC5B expression levels (Source: UniProt)

Beyond the preview

Go deeper on Respiratory mucus mucoproteins and extracellular DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory mucus mucoproteins and extracellular DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call